Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
jarushka Naidoo
Apr 23, 2024, 23:25 |
Drugs
Jarushka Naidoo: Pooled 5-year outcomes of Pembrolizumab and Chemotherapy for PDL less than 1% metastatic NSCLC in the Journal of Thoracic Oncology
Jarushka Naidoo shared on X: “Pooled 5-yr outcomes of Pembrolizumab and Chemotherapy for PDL1<1% metastatic…
Apr 18, 2024, 14:58 |
Blog
Jarushka Naidoo: A wonderful weekend with lung cancer leaders and friends at AILCC24
Jarushka Naidoo recently shared on LinkedIn: "A wonderful weekend with lung cancer leaders and friends…
Apr 16, 2024, 01:50 |
Blog
Jarushka Naidoo: Starting day 2 with Patrick Forde on periop chemo-IO in nsclc
Jarushka Naidoo shared on X/Twitter: "AILCC24 Starting day 2 with Patrick Forde on periop chemoIO in nsclc.…
Apr 11, 2024, 13:50 |
Insight
New blood test predicts clinical benefit to IO AND identifies which patient will develop toxicity by Jarushka Naidoo - LUNGevity Foundation
LUNGevity Foundation shared on X/Twitter: "50% patients develop side effects from immunotx. New blood test predicts…
Apr 3, 2024, 15:42 |
Drugs
Jarushka Naidoo: Phase II trial of Tumor-Infiltrating Lymphocyte (TIL) therapy (Lifileucel) in Advanced Non-Small Cell Lung Cancer post Immunotherapy with or without chemotherapy
Apr 1, 2024, 23:46 |
Insight
Jarushka Naidoo: Spectrum of ICI toxicity in last 10 years
Jarushka Naidoo shared on X/Twitter: "Spectrum of ICI toxicity in last 10 years: - Vigibase…
Mar 29, 2024, 18:40 |
Insight
Jarushka Naidoo: Ph III KRYSTAL-12 Trial of 2nd-line Adagrasib in KRAS G12C+ NSCLC meets primary PFS endpoint
Jarushka Naidoo shared on X/Twitter: "Ph III KRYSTAL-12 Trial of 2nd-line Adagrasib in KRAS G12C+…
Mar 27, 2024, 14:11 |
Blog
Stephen V Liu: ELCC24 Great discussion of Antibody drug conjugates toxicity from Dr. Jarushka Naidoo, noting that each component of the antibody drug conjugate will impact toxicity
Mar 25, 2024, 15:09 |
Insight
Jarushka Naidoo: Surgical outcomes of RATIONALE-315 (Neoadjuvant Tis + chemo in resectable NSCLC)
Jarushka Naidoo recently posted on X: "Surgical outcomes of RATIONALE-315 (Neoadjuvant Tis+chemo in resectable NSCLC): -…
Mar 24, 2024, 23:26 |
Blog
Jarushka Naidoo: ESMO Young Oncologists (YO) session on career navigation with Herbert Loong, Lizza Hendriks, Alfredo Addeo & I
Jarushka Naidoo shared a post on X: “ELCC24 ESMO Young Oncologists (YO) session on career…
3
4
5
6
7
All:
118
Posts:
41 - 50
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Ben Stiller and Prostate Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube